Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.99 USD | -5.23% | -23.71% | -29.38% |
May. 16 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
May. 16 | Monte Rosa Therapeutics Prices $100 Million Public Offering | MT |
Business Summary
Number of employees: 130
Managers
Managers | Title | Age | Since |
---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 53 | 19-12-31 |
Chief Operating Officer | - | 21-02-28 | |
Filip Janku
CTO | Chief Tech/Sci/R&D Officer | 50 | 21-05-31 |
Sharon Townson
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-06-30 |
John Castle
CTO | Chief Tech/Sci/R&D Officer | 54 | 20-04-30 |
Philip Nickson
LAW | General Counsel | 45 | 21-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
CHM | Chairman | 58 | 20-08-31 |
Christine Siu
BRD | Director/Board Member | 47 | 20-11-30 |
Chandra Paul Leo
BRD | Director/Board Member | 53 | 20-08-31 |
Ali Behbahani
BRD | Director/Board Member | 48 | 20-03-31 |
Anthony Manning
BRD | Director/Board Member | 62 | 23-07-24 |
Markus Warmuth
CEO | Chief Executive Officer | 53 | 19-12-31 |
Jan Skvarka
BRD | Director/Board Member | 57 | 23-03-22 |
Director/Board Member | 55 | 20-05-31 | |
Alexander Mayweg
BRD | Director/Board Member | 49 | 18-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 60,848,785 | 60,405,481 ( 99.27 %) | 10,005 ( 0.0164 %) | 99.27 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.38% | 257M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- GLUE Stock
- Company Monte Rosa Therapeutics, Inc.